Healthy Adult Volunteers

6

Review clinical trials related to Healthy Adult Volunteers. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides

This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics effects of a single dose of FXR0906 injection or placebo in Chinese healthy adult volunteers with or without TG increase.

Participants needed: 24
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.Updated: Aug 14, 2026Locations: 1
Eligibility criteria

History or presence of clinically significant diseases/abnormality, or with clin... [+5]

Status: Recruiting

The Effects of the Yi Jin Jing on the Muscles and Bones of Adults

Observation of the effects of Yi Jin Jing on the muscles and bones of adults

Participants needed: 50
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: Beijing Hospital of Traditional Chinese MedicineUpdated: Aug 12, 2026Locations: 1
Eligibility criteria

Age 18-90 years inclusive; [+5]

Presence of acute or unstable chronic diseases (e.g., uncontrolled hypertension,... [+6]

Status: Not yet recruiting

Multiple Ascending Dose Study of DW4421

Multiple Ascending Dose of DW4421, phase I

Participants needed: 56
Trial details
Phase: Phase 1Age: 19-50Biological sex: AllType: InterventionalSponsor: Daewon Pharmaceutical Co., Ltd.Updated: Jul 8, 2026Locations: 1
Eligibility criteria

Healthy adult aged 19 to 50 (inclusive) years, at the time of screening. [+1]

Those who have clinical significant liver, kidney, nervous system, respiratory,...

Status: Recruiting

Immun4Cure Cohort of Autoimmune Diseases

This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, MontpellierUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Adults ≥18 years [+11]

Patients who have refused or are unable to give informed consent [+7]

Status: Recruiting

Effects of Plant Foods on Gastrointestinal and Cardiometabolic Health

The aim of this randomised controlled trial is to investigate the effects of plant foods on gastrointestinal and cardiometabolic health in healthy adults aged 30-70 years old. The main question it will answer is "what is the effect of plant foods on alpha-diversity of the gut microbiota?". Researchers will compare two diets containing plant foods to see if they have different effects on gastrointestinal and cardiometabolic health. Participants will be asked to replace all their meals, snacks and drinks with those provided by the study team for four weeks (6 days/week). Participants will also be asked to attend the research facility on three occasions to: * Provide a blood sample * Provide a urine sample * Provide a stool sample * Have their body composition assessed * Have an ultrasound of their artery (arm) * Have their blood pressure measured * Answer questionnaires related to dietary intake, mental health, physical activity, quality of life, diet acceptability and adherence

Participants needed: 248
Trial details
Age: 30-70Biological sex: AllType: InterventionalSponsor: King's College LondonUpdated: May 14, 2026Locations: 1
Eligibility criteria

Adults aged 30-70 years of age [+9]

Medical history of any of the following: diabetes, major active or historic psyc... [+11]

Status: Not yet recruiting

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin

Participants needed: 36
Trial details
Phase: Phase 1Age: 19-50Biological sex: AllType: InterventionalSponsor: Daewon Pharmaceutical Co., Ltd.Updated: Feb 4, 2026Locations: 1
Eligibility criteria

Healthy adult aged 19 to 50 (inclusive) years, at the time of screening. [+1]

Those who have clinical significant liver, kidney, nervous system, respiratory,...